Form 4 holding
President & CEO, Director
Sana Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 7,944,251
- Estimated value
- $30,108,711
- Report date
- 09 Mar 2026
- Price
- $3.79
- Ownership
- Direct
Steve Harr
Insider Reports History
- Reporting-owner location
- Seattle, WA
- Latest reporting-owner signature
- /s/ Aaron M. Grossman, Attorney-in-Fact for Steve Harr
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Steve Harr
Form 4 holding
President & CEO, Director
Sana Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 682,500
- Estimated value
- $2,586,675
- Report date
- 06 Mar 2026
- Price
- $3.79
- Ownership
- Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015
Form 4 holding
President & CEO, Director
Sana Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 167,000
- Estimated value
- $632,930
- Report date
- 06 Mar 2026
- Price
- $3.79
- Ownership
- Held by Brian L Harr TTEE CCH Irrevocable Trust U/A DTD 03/25/2021
Form 4 holding
President & CEO, Director
Sana Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 167,000
- Estimated value
- $632,930
- Report date
- 06 Mar 2026
- Price
- $3.79
- Ownership
- Held by Brian L Harr TTEE JOH Irrevocable Trust U/A DTD 03/25/2021
Form 4 holding
President & CEO, Director
Sana Biotechnology, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 100,000
- Estimated value
- $384,000
- Report date
- 07 Mar 2026
- Price
- $2.56
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President & CEO, Director
Sana Biotechnology, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 900,000
- Estimated value
- Report date
- 05 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Steve Harr
4
SANA
Sana Biotechnology, Inc.
- Report period
- 06 Mar 2026
- Transactions
- 6
- Transaction value
- $0
- Accepted by SEC
- 10 Mar 2026, 16:16
- Role
- President & CEO, Director
- Next action
- Open filing details
4
SANA
Sana Biotechnology, Inc.
- Report period
- 05 Mar 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 06 Mar 2026, 16:52
- Role
- President & CEO, Director
- Next action
- Open filing details
4
SANA
Sana Biotechnology, Inc.
- Report period
- 06 Mar 2025
- Transactions
- 5
- Transaction value
- -$32,819
- Accepted by SEC
- 10 Mar 2025, 20:12
- Role
- President & CEO, Director
- Next action
- Open filing details
4
SANA
Sana Biotechnology, Inc.
- Report period
- 07 Mar 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 08 Mar 2024, 16:18
- Role
- President & CEO, Director
- Next action
- Open filing details
4
SANA
Sana Biotechnology, Inc.
- Report period
- 02 Mar 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 03 Mar 2023, 15:35
- Role
- President & CEO, Director
- Next action
- Open filing details
4
SANA
Sana Biotechnology, Inc.
- Report period
- 03 Mar 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 08 Mar 2022, 08:08
- Role
- President & CEO, Director
- Next action
- Open filing details
4
SANA
Sana Biotechnology, Inc.
- Report period
- 14 Apr 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 15 Apr 2022, 19:14
- Role
- President & CEO, Director
- Next action
- Open filing details